Barclays initiates Edwards Lifesciences at Overweight, $110 target
Barclays initiated Edwards Lifesciences with an Overweight rating and a $110.00 per-share price target.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.